Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

18 Jul, 2019, 11:00 BST Liquid Biopsy Performance Comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS Testing Published in Scientific Reports (Nature Journal)

Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces...


18 Jul, 2019, 07:37 BST Sosei Heptares to Receive US$2.5 Million Milestone Payment from Formosa Pharmaceuticals

Sosei Group Corporation ("the Company"; TSE: 4565) announces that Formosa Pharmaceuticals, Inc. ("Formosa") has received approval from the US Food...


17 Jul, 2019, 20:45 BST AAIC® 2019 Highlights New Research Showing Healthy Lifestyle May Offset Environmental and Genetic Risk of Alzheimer's Disease

Research presented at the Alzheimer's Association International Conference (AAIC) 2019 in Los Angeles suggests adopting multiple healthy lifestyle...


17 Jul, 2019, 13:25 BST Unique Hybrid Implant First Installed to Cat

Scientific team of a small innovative enterprise Biomimetix, based on the National University of Science and Technology MISIS together with their...


16 Jul, 2019, 12:30 BST Clinical Trials Market is Projected to Record a 4.5% CAGR Through 2029 - Future Market Insights

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018....


15 Jul, 2019, 17:30 BST Advances In The Global Search For Blood Markers For Alzheimer's Disease And Other Dementias

Significant advances in the global search for blood test technologies for Alzheimer's disease and other dementias were reported at the Alzheimer's...


15 Jul, 2019, 14:02 BST Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure, today announced enrollment...


15 Jul, 2019, 12:00 BST Alkermes Expands Planned New Drug Application for ALKS 3831 to Include Treatment of Bipolar I Disorder

Alkermes plc (Nasdaq: ALKS) today provided an update on its regulatory strategy for ALKS 3831 (olanzapine/samidorphan), the company's...


15 Jul, 2019, 05:12 BST Okayama University Research: Early Gastric Cancer Endoscopic Diagnosis System Using Artificial Intelligence

Researchers at Okayama University have developed an early gastric cancer endoscopic diagnosis system using artificial intelligence (AI). The details...


12 Jul, 2019, 09:32 BST Cyxone Announce Dosing of First Volunteer in T20K's First-in-human Trial

Cyxone (publ.) a Swedish biotech in autoimmune diseases, today announced that the first healthy male volunteer has received the initial dose in its...


11 Jul, 2019, 18:16 BST MeRes100 BRS - the World's First Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffold - Shows Consistent Long-term Positive Safety With Consistent Low MACE Rates and Zero Scaffold Stent Thrombosis for Patients With Coronary Artery Disease

Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold thrombosis and very...


11 Jul, 2019, 14:03 BST Nordic Nanovector Completes Patient Enrolment Into Phase 1 Trial of Betalutin® in Diffuse Large B-cell Lymphoma (DLBCL)

Nordic Nanovector ASA (OSE: NANO) announces that the final patient has been enrolled in the LYMRIT 37-05 clinical trial of Betalutin®...


10 Jul, 2019, 12:27 BST iSTAR Medical's MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)

iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent...


09 Jul, 2019, 14:22 BST ConTIPI Medical Has Received FDA Approval for the Marketing of a Unique Product for the Treatment of Pelvic Organ Prolapse in Women

This week, ConTIPI Medical Ltd. received US Food and Drug Administration (FDA) approval to market its new product, the first of its kind, designed to ...


09 Jul, 2019, 12:00 BST EIP Pharma Initiates New Study with Neflamapimod for the Treatment of Cognitive Deficits in Patients with Huntington's Disease

EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod...


09 Jul, 2019, 09:00 BST Impossible Is Possible: Scientists Discover Chemically-"Unreal" Modifications of a Material

NUST MISIS scientists together with colleagues (Germany, Sweden and Russia) proved the possibility of creating materials, which were considered...


08 Jul, 2019, 20:15 BST icotec AG Granted FDA Clearance To Market VADER®one Pedicle Screw System

icotec AG, a Swiss company, today announced the VADER®one pedicle screw system was granted U.S. Food and Drug Administration (FDA) 510(k) clearance...


08 Jul, 2019, 17:48 BST Targovax Announces Encouraging Results From Part 1 of the ONCOS-102 and Keytruda Combination Trial in Anti-PD1 Refractory Melanoma

Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing oncolytic viruses to target hard-to-treat solid tumors, today announces...


08 Jul, 2019, 13:30 BST Growing Adoption of SaaS Encouraging Confident Shifts Across Clinical Trial Management Systems Market, Reports Fact.MR Study

To be precise, clinical trial management systems are fundamental to eClinical environments, and looking at the dominant focus on product welfare and...


08 Jul, 2019, 07:00 BST 4D pharma plc Commences Phase I/II Asthma Trial

4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutics, today announces an update on its lead Live...


05 Jul, 2019, 08:33 BST Cyxone Submits First Application to Start Clinical Phase IIb Trial With Rabeximod

Cyxone (publ), a Swedish biotech in autoimmune diseases, today submitted an application to the Central Ethics Committee (CEC) in Poland for...


04 Jul, 2019, 13:46 BST NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has initiated the second part in its ongoing...


04 Jul, 2019, 10:13 BST Kleresca® Strengthens Scientific Proof of Fluorescent Light Energy (FLE) in New Study

In a recent, peer-reviewed study, Kleresca® presents documentation that its unique FLE technology is able to reduce inflammation in the skin, enhance ...


04 Jul, 2019, 08:01 BST Cantargia Announce Full Recruitment of CAN04 Monotherapy arm in Ongoing Phase IIa Clinical Trial

Cantargia´s antibody CAN04 (nidanilimab) is investigated in an open label three-armed phase IIa clinical trial, CANFOUR. Here, CAN04 is examined as...


03 Jul, 2019, 13:30 BST ALTEN Calsoft in Partnership With Clinlogix Launches Blockchain for Clinical Trials

ALTEN Calsoft Labs, a leading Enterprise Digital Transformation solutions and Engineering R&D services company, has launched – "BioPharma Ledger", a...